These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Enhancement by nifedipine of cholinergic-induced depression of locomotor activity in mice. Sansone M; Battaglia M; Pavone F Funct Neurol; 1995; 10(4-5):163-7. PubMed ID: 8749042 [TBL] [Abstract][Full Text] [Related]
26. Calcium channel activation and self-biting in mice. Jinnah HA; Yitta S; Drew T; Kim BS; Visser JE; Rothstein JD Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15228-32. PubMed ID: 10611367 [TBL] [Abstract][Full Text] [Related]
28. Effects of calcium antagonists on phencyclidine behaviors. Bolger GT; Rafferty MF; Crawley JN; Paul SM; Skolnick P Pharmacol Biochem Behav; 1986 Jul; 25(1):45-9. PubMed ID: 3749237 [TBL] [Abstract][Full Text] [Related]
29. Effects of various Ca2+ channel antagonists on morphine analgesia, tolerance and dependence, and on blood pressure in the rat. Michaluk J; Karolewicz B; Antkiewicz-Michaluk L; Vetulani J Eur J Pharmacol; 1998 Jul; 352(2-3):189-97. PubMed ID: 9716354 [TBL] [Abstract][Full Text] [Related]
30. Uptake of calcium antagonistic drugs into muscles as related to their lipid solubilities. Pang DC; Sperelakis N Biochem Pharmacol; 1984 Mar; 33(5):821-6. PubMed ID: 6608945 [TBL] [Abstract][Full Text] [Related]
31. Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes. Boles RG; Yamamura HI; Schoemaker H; Roeske WR J Pharmacol Exp Ther; 1984 May; 229(2):333-9. PubMed ID: 6716261 [TBL] [Abstract][Full Text] [Related]
32. Do calcium antagonists act directly on calcium channels to alter baroreceptor function? Kunze DL; Andresen MC; Torres LA J Pharmacol Exp Ther; 1986 Nov; 239(2):303-10. PubMed ID: 2430091 [TBL] [Abstract][Full Text] [Related]
34. Potentiating effects of L-type Ca(2+) channel blockers on pentobarbital-induced hypnosis are influenced by serotonergic system. Zhao X; Cui XY; Chu QP; Chen BQ; Wang XM; Lin ZB; Li XJ; Ku BS; Zhang YH J Neural Transm (Vienna); 2006 Oct; 113(10):1395-402. PubMed ID: 16465463 [TBL] [Abstract][Full Text] [Related]
35. [Calcium channel blockers as antidepressants--a property of the class or of the individual preparation?]. Kozlovskiĭ VL; Prakh'e IV Eksp Klin Farmakol; 1994; 57(1):17-20. PubMed ID: 8142855 [TBL] [Abstract][Full Text] [Related]
36. High-affinity antibodies to the 1,4-dihydropyridine Ca2+-channel blockers. Campbell KP; Sharp A; Strom M; Kahl SD Proc Natl Acad Sci U S A; 1986 May; 83(9):2792-6. PubMed ID: 3010317 [TBL] [Abstract][Full Text] [Related]
37. L-type Ca(2+) channel blockers inhibit the development but not the expression of sensitization to morphine in mice. Zhang Q; Li JX; Zheng JW; Liu RK; Liang JH Eur J Pharmacol; 2003 Apr; 467(1-3):145-50. PubMed ID: 12706468 [TBL] [Abstract][Full Text] [Related]
38. Effects of calcium channel blockers on neuromuscular blockade induced by aminoglycoside antibiotics. Del Pozo E; Baeyens JM Eur J Pharmacol; 1986 Aug; 128(1-2):49-54. PubMed ID: 3758187 [TBL] [Abstract][Full Text] [Related]
39. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms. Millard RW; Lathrop DA; Grupp G; Ashraf M; Grupp IL; Schwartz A Am J Cardiol; 1982 Feb; 49(3):499-506. PubMed ID: 6277175 [TBL] [Abstract][Full Text] [Related]
40. Stimulatory influences of calcium channel antagonists on stress-induced opioid analgesia and locomotor activity. Kavaliers M Brain Res; 1987 Apr; 408(1-2):403-7. PubMed ID: 2439174 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]